USA - NASDAQ:DRNA - Common Stock
Taking everything into account, DRNA scores 10 out of 10 in our technical rating. Both in the recent history as in the last year, DRNA has proven to be a steady performer, scoring decent points in every aspect analyzed.
DRNA has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 38.26. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 38.04, a Stop Loss order could be placed below this zone. We notice that large players showed an interest for DRNA in the last couple of days, which is a good sign.
19.48
When analyzing the support we can see 5 important areas.
We can see 2 important resistance areas.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | UP | POSITIVE | The long term trend for DRNA is up. |
| ChartMill Short Term Trend Indicator | UP | POSITIVE | The short term trend for DRNA is up. |
| ChartMill Relative Strength | 98.23 | POSITIVE | DRNA has a high relative strength, it outperformed 98.23% off all stocks on the market. |
| Simple Moving Average/SMA (20) | UP | POSITIVE | The current price of DRNA is above the rising SMA(20). |
| Simple Moving Average/SMA (50) | UP | POSITIVE | The current price of DRNA is above the rising SMA(50). |
| Simple Moving Average/SMA (200) | UP | POSITIVE | The current price of DRNA is above the rising SMA(200). |
| Relative Strength Index/RSI (14) | 82.28 | OVERBOUGHT | The high RSI value suggests DRNA may be overbought. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | -0.58 | NEGATIVE | The MACD value suggests DRNA has a negative trend, although the MACD value is rising. |
| Stochastics (14,3) | 66.41 | NEUTRAL | The Stochastics value for DRNA is a neutral value. |
| Average True Range in percent/ATR (20) | 0.56 | LOW VOLATILITY | The low ATR as a percentage value for DRNA suggests low volalility. |
Important!: this is just an example which is fully automatically generated based on the analysis above and should in no way be interpreted as a suggestion. Always make your own analysis and determine your own entry and exit points.
| ENTRY | EXIT | DISTANCE | CAPITAL |
|---|---|---|---|
| 38.27 | 37.79 | 0.48 (1.25%) | 25.00% |
| An entry @38.27. This is a Buy Stop order right above the resistance zone. | An exit @37.79. This is a Stop Loss order right below the 10 day low. | The trade has a worst case loss of 0.48 points, which is 1.25%. | For a 0.31% total portfolio risk, you can invest 25.00% of your capital in this trade. |
38.22
+0.22 (+0.58%)
ChartMill assigns a technical rating of 9 / 10 to DRNA.
The current trend direction for Dicerna Pharmaceuticals Inc (DRNA) is Bullish.
Dicerna Pharmaceuticals Inc (DRNA) has an RSI value of 82.2809. This indicates that the stock is currently overbought.
The short term momentum for Dicerna Pharmaceuticals Inc (DRNA) is positive.
The buy/sell signal for Dicerna Pharmaceuticals Inc (DRNA) is buy as both the short term and long term trends are positive.